Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype?

OBJECTIVES: Advancements in non-small cell lung cancer treatment based on targeted therapies have made the differentiation between adenocarcinoma and squamous cell carcinoma increasingly important. Pathologists are challenged to make the correct diagnosis in small specimens. We studied the accuracy...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardi, Fabiola Del Carlo, Bernardi, Marcela Del Carlo, Takagaki, Teresa, Siqueira, Sheila Aparecida Coelho, Dolhnikoff, Marisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201148/
https://www.ncbi.nlm.nih.gov/pubmed/30379223
http://dx.doi.org/10.6061/clinics/2018/e361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201148/
https://www.ncbi.nlm.nih.gov/pubmed/30379223
http://dx.doi.org/10.6061/clinics/2018/e361

Ejemplares similares